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T
his article reviews progress in adapting addiction treatment to respond more fully to the chronic nature of most patients’
problems. After reviewing evidence that the natural history of addiction involves recurrent cycles of relapse and recovery, 
we discuss emerging approaches to recovery management, including techniques for improving the continuity of care, monitoring
during periods of abstinence, and early reintervention; recent developments in the field related to self-management, mutual aid,
and other recovery supports; and system-level interventions. We also address the importance of adjusting treatment funding and
organizational structures to better meet the needs of individuals with a chronic disease.
H
istorically, addiction treatment systems and research have been organ-
ized to provide and improve the outcomes of acute episodes of care. The
conceptual model has been that an addicted person seeks treatment,
completes an assessment, receives treatment, and is discharged, all in a period of
weeks or months. This orientation stands at variance with clinical experience and
studies conducted over several decades, which confirm that, although some indi-
viduals can be successfully treated within an acute care framework, more than half
the patients entering publicly funded addiction programs require multiple episodes
of treatment over several years to achieve and sustain recovery (Dennis et al., 2005;
Dennis, Foss, and Scott, 2007). The progress of many patients is marked by cycles
of recovery, relapse, and repeated treatments, often spanning many years before even-
tuating in stable recovery, permanent disability, or death (Anglin et al., 2001; Anglin,
Hser, and Grella, 1997; Dennis, Scott, and Funk, 2003; Hser et al., 1997, 2001;
McLellan et al., 2000; Scott, Dennis, and Foss, 2005; Scott, Foss, and Dennis, 2005;
Simpson, Joe, and Broome, 2002; Weisner et al., 2004; Weisner, Matzger, and
Kaskutas, 2003; White, 1996).
The traditional acute care approach to drug abuse has encouraged people to sup-
pose that patients entering addiction treatment should be cured and able to main-
tain lifelong abstinence following a single episode of specialized treatment. Accordingly,
policymakers allocate limited public health dollars for addiction treatment; insurers
restrict the number of patient days and visits covered; treatment centers make no
infrastructure allowance for ongoing monitoring; and families and the public become
impatient when patients relapse (McLellan et al., 2000). 4 6 •   A D D I C T I O N   S C I E N C E   &   C L I N I C A L   P R A C T I C E — D E C E M B E R   2 0 0 7
The mismatch between the typical natural history
of substance use disorders (SUDs) and treatment mod-
els and expectations reduces our ability to help addicted
individuals. In this overview, we define SUDs, highlight
their chronic features, discuss several recently developed
techniques to manage SUDs over time, and present infor-
mation that can help guide systems and programs in
adapting to a chronic care approach to SUDs.
CHRONICITY OF SUDS 
The American Psychiatric Association (APA; 2000) and
World Health Organization (WHO; 1999) define addic-
tion as a chronic, tenacious pattern of substance use and
related problems; they distinguish two types of SUDs:
dependence and abuse (the latter called “hazardous use”
by the WHO). The definition of substance dependence
implies chronicity: Symptoms—including increased tol-
erance for the substance, inability to abstain, replace-
ment of healthy activities with substance use, and con-
tinued use despite medical or psychological problems—
have been present for longer than 12 months and are
likely to persist if left untreated. Substance abuse applies
when people do not meet the dependence criteria, but
report at least one moderately severe substance-related
symptom that puts them at high risk for harming them-
selves or others and for developing dependence. Depend-
ence requires treatment, and abuse generally results in
referral to brief intervention or treatment.
A growing body of neuroimaging studies provides
evidence that a physiological basis underlies the clinical
experience of SUD chronicity (Fowler et al., 2007).
These studies demonstrate that cravings, cue reactivity,
tolerance, and withdrawal can be seen in the brain; that
they interact with brain development (particularly among
adolescents); that they respond to medications as well
as social and physical environment; and that chronic
substance use is associated with physical changes in
the brain that have an impact on brain functioning and
emotional states (Chang et al., 2005, 2006; Kufahl et
al., 2005; Paulus, Tapert, and Schuckit, 2005; Risinger
et al., 2005; Schlaepfer et al., 2006; Volkow, Fowler, and
Wang, 2003, 2004).
Epidemiological Indicators of Chronicity
Of the 235 million people aged 12 and over in the U.S.
household population in 2001, 5 percent met the cri-
teria for substance dependence, and 4 percent met the
criteria for substance abuse in the past year (Office of
Applied Studies (OAS), 2002). Epidemiological data
affirm that SUDs typically follow a chronic course, devel-
oping during adolescence and lasting for several decades.
Some 90 percent of all individuals with dependence
started using before the age of 18, and half started before
the age of 15 (Dennis et al., 2002). In the U.S. popu-
lation as a whole, the prevalence of dependence and
abuse rises through the teen years, peaks at around 20
percent between ages 18 and 20, then declines gradu-
ally over the next four decades (Figure 1; OAS, 2002).
A significant portion of older nonusers are people in
recovery. In studies of community (Dawson, 1996;
Kessler, 1994; Robins and Regier, 1991) and treatment
(Dennis et al., 2005) populations, between 58 and 60
percent of people who met the criteria for an SUD at
some time in their lives eventually achieved sustained
recovery—that is, they had no dependence or abuse
symptoms for the past year. Most who recover do so only
after at least one episode of treatment (Cunningham,
1999a, 1999b).
People who enter treatment are a distinct sub-
group of substance users whose problems are particu-
larly severe and intractable. Among people in publicly
funded addiction treatment in 2002, 62 percent met the
diagnostic criteria for dependence; 16 percent met the
criteria for abuse; and 22 percent were admitted for other
subclinical substance-related problems (e.g., acute intox-
ication, mental health problems aggravated by substance
use; OAS, 2005). Of people admitted to U.S. public
In the U.S. household population in 2001, the percentage of people who reported
substance dependence or abuse rose through the adolescent age groups to peak
among the 18- to 20-year-olds, and declined through subsequent age groups 
(OAS, 2002).
FIGURE 1. Substance Use Disorders Begin in Adolescence and Last
for Decades
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programs in 2003, 64 percent were reentering treatment:
23 percent for the second time, 22 percent for the third
or fourth time, and 19 percent for the fifth or more time
(OAS, 2005). In fact, numerous longitudinal studies
have shown that, on average, people reach sustained
abstinence only after three to four episodes of differ-
ent kinds of treatment over a number of years (Anglin,
Hser, and Grella, 1997; Dennis et al., 2005; Grella and
Joshi, 1999; Hser et al., 1997, 1998; Scott, Dennis, and
Foss, 2005; Scott, Foss, and Dennis, 2005). In one lon-
gitudinal study with 1,271 patients, the estimated median
time from first use to at least 1 drug-free year was 27
years, and the median time from first treatment to 1
alcohol- and drug-free year was 9 years with three to four
episodes of treatment (Dennis et al., 2005).
In sum, most patients in publicly funded addic-
tion treatment have SUDs and require multiple treat-
ment episodes over several years to reach stable recov-
ery. For optimal outcomes, treatment systems and
interventions should be able to address the long-term
aspects and cyclical dynamics of the disorder.
Inside the Cycles of Recovery and Relapse
In a recent study, Scott and colleagues provided insight
into the factors influencing 448 patients’ transitions
between relapse, treatment reentry, incarceration, and
recovery (Scott, Dennis, and Foss, 2005). Over 2
years of monitoring, 82 percent transitioned at least
once, and 62 percent moved multiple times (Figure
2). In an average quarter, 32 percent of the patients
moved from one status to another.
Several variables predicted the transitions. Patients
with higher substance use severity and environmental
obstacles to recovery—for example, substance use in the
home, family problems, and victimization—were less
likely to transition from drug use to recovery or treat-
ment (i.e., the individuals most in need of treatment
were the least likely to re-enroll on their own). Patients
were more likely to transition from use to recovery when
they believed their problems could be solved, desired
help with their problems, reported high self-efficacy
to resist substance use, and received addiction treatment
during the quarter.
Scott and colleagues conducted a second study, this
time with 1,326 adult patients over a 3-year period, that
looked at annual transitions (Scott, Foss, and Dennis,
2005). More than 83 percent of the participants tran-
sitioned from one point in the cycle to another during
the 3 years (including 36 percent who transitioned twice
and 14 percent who transitioned three times). Treatment
participation was again a primary correlate of the tran-
sition from use to recovery. The odds ratio of transi-
tioning from use to recovery went up 1.14 for every 9
weeks of treatment received during the year. Among
patients who started the year in recovery, the major pre-
dictor of whether they maintained abstinence was not
treatment, but their level of self-help group participa-
tion. The odds ratio of relapse went down 0.55 for every
77 days of self-help group attendance. 
Factors Affecting the Duration of SUDs 
The age at first substance use and the duration of use
before starting treatment are related to the length of time
it takes people to reach at least 1 year of alcohol and drug
abstinence. Scott and colleagues found that the median
time of use was significantly longer for people who started
before age 15 than for those who started after age 20 (29
vs. 18 years; Scott, Dennis, and Foss, 2005). Patients
who began treatment within 10 years of their initial drug
use achieved a year or more of abstinence after an aver-
age of 15 years, compared with 35 or more years among
those who entered treatment after 20 or more years of
use. These results clearly establish the need to diag-
nose and intervene as early as possible, ideally during
the first decade of use.
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Over a 2-year period, 82 percent of drug users transitioned one or more times
between use, incarceration, treatment, and recovery. An average of 32 percent
changed every 90 days, with movement in every direction and treatment increas-
ing the likelihood of getting to recovery (Scott, Foss, and Dennis, 2005).
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The Impact of Co-Occurring Problems
As clinicians and researchers are aware, individuals with
SUDs have high rates of additional health and social
burdens that increase the difficulty of treatment: psy-
chiatric problems, HIV risk behaviors, violence, ille-
gal activity and involvement in the criminal justice sys-
tem, service utilization, homelessness, and a wide range
of vocational problems (Center for Substance Abuse
Treatment, 2000; Compton, Lamb, and Fletcher, 1995;
Epstein, 2002; Grant, 2000; Hasin et al., 1997a, 1997b;
Jaffe, 1993; Kessler et al., 1996; Langenbucher, Morgen-
stern, and Miller, 1995; Lennox, Scott-Lennox, and
Bohlig, 1993; Lennox, Scott-Lennox, and Holder, 1992;
Lennox, Zarkin, and Bray, 1996; Mark et al., 2001;
Regier et al., 1990; Woody, Cottler, and Cacciola, 1993).
Patients who abuse multiple substances or have other
co-occurring problems are more likely to experience dif-
ficulties with treatment/medication adherence, shorter
stays, administrative discharges, compromised func-
tional status, difficult community adjustment, reduced
quality of life, and worse outcomes (e.g., Brooner et al.,
1997; Ford, Snowden, and Walser, 1991; Hien et al.,
1997; McLellan et al., 1983; Mueser et al., 1990; Project
MATCH Research Group, 1997; Ross, Glaser, and
Germanson, 1988; Rounsaville et al., 1982, 1986;
Weisner, Matzger, and Kaskutas, 2003; White et al.,
2005). Clinical trials have demonstrated that when
patients have an SUD combined with one or more non-
substance-related disorders, it can be more effective—
in terms of both clinical outcome and cost—to provide
integrated care (Parthasarathy et al., 2003; Willenbring,
2005). 
EMERGING APPROACHES TO RECOVERY 
MANAGEMENT
Recently, clinicians and researchers have generated sev-
eral new approaches to improve the long-term man-
agement of an SUD by responding to its chronic nature.
Underlying the approaches are three strategies:
• Improve the continuity of care;
• Use monitoring and early reintervention; and
• Provide other recovery support.
Improving Continuity of Care
During the years- or decades-long course of an SUD,
patients need varying levels of care. In periods of inten-
sified symptoms, a patient may be able to cope best by
retreating from the community to a specialized inpa-
tient or intensive outpatient setting. Conversely, reen-
try into the community at the conclusion of an inten-
sive treatment episode marks the beginning of a new
state of risk related to continuing biobehavioral vul-
nerability and environmental exposures.
Accordingly, the APA (1995), the American Society
of Addiction Medicine (2001), and the Department of
Veterans Affairs Office of Quality and Performance
(www.oqp.med.va.gov/cpg/SUD/SUD_Base.htm) have
issued clinical practice guidelines recommending that
patients being discharged from intensive levels of addic-
tion treatment be transferred to outpatient treatment
for a period of time before leaving the addiction treat-
ment system. A number of studies demonstrate that this
practice promotes continuation of abstinence and reduces
the likelihood of arrest (e.g., Brown et al., 1994; Donovan,
1998; Gilbert, 1988; Godley et al., 2007; Higgins, Badger,
and Budney, 2000; Ito and Donovan, 1986; Kosten et
al., 1992; McKay, 2001; McKay et al., 1998; Moos et
al., 2001; Moos and Moos, 2003; Ouimette, Moos, and
Finney, 1998; Peterson et al., 1994; Ritsher et al., 2002;
Ritsher, Moos, and Finney, 2002; Sannibale et al., 2003;
Walker et al., 1983). Also, in one of the few economic
evaluations of long-term management of chronic SUDs,
French and colleagues (2000) found that while the out-
lay to provide a full continuum of inpatient and outpa-
tient care was greater than that for outpatient treatment
alone ($2,530 vs. $1,138; p < 0.05), the cost differen-
tial was offset by significantly greater reductions in soci-
etal costs over the subsequent 9 months (savings of
$17,833 vs. $11,173; p < 0.05).
Despite the benefits associated with continuing care,
a study of discharge patterns in 23 states and jurisdic-
tions showed that although 58 percent of patients suc-
cessfully completed detoxification, hospital, residential
treatment, or intensive outpatient programs, only about
17 percent of these individuals proceeded to regular out-
patient care (OAS, 2005). Studies focusing on single
correctional, drug court, residential, intensive outpa-
tient, and detoxification programs have found, similarly,
that 25 to 90 percent of discharged individuals do not
successfully access the recommended outpatient con-
tinuing care (Godley et al., 2002; Godley, Godley, and
Dennis, 2001; Mark et al., 2003; McCorry et al., 2000;
McKay et al., 2002; OAS, 2005; Taxman, 2002). Com-
mon reasons for low success rates in bridging patients
into continuing care include relying on patients’ self-
motivation to follow through with discharge recom-
mendations, discharging patients to geographically large
catchment areas (particularly from criminal/juvenile jus-
Systems that
offer both
inpatient and
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tice and adolescent residential programs) where followup
services are not easily accessed, and passively linking
patients to other organizations or staff without proactive
efforts to ensure continuity of care.
Recent studies have evaluated new and more assid-
uous protocols to improve participation in continuing
care (Ciliska et al., 1996; Godley et al., 2002, 2007;
McKay et al., 2004; Simon et al., 2004; Slesnick and
Prestopnik, 2004; Zhu et al., 1996). As an example,
McKay and colleagues (2004, 2005) demonstrated ben-
efits with telephone-based continuing care. The researchers
randomly assigned 359 alcohol- or cocaine-dependent
adults who had completed a 4-week intensive outpatient
program to one of three continuing care protocols: (a)
twice weekly standard outpatient treatment for 12 weeks;
(b) twice weekly relapse prevention group therapy for
12 weeks; or (c) 4 weeks of relapse prevention group
therapy and 12 weeks of therapist-initiated telephone
contact. Over the course of the study, the participants
who were telephoned had significantly fewer positive
cocaine urine tests than those in group b (odds ratio
0.80) or group a (odds ratio 0.26). The results also sug-
gest that telephone delivery of continuing care may be
most effective for persons whose SUD is less severe; par-
ticipants with high dependence levels or co-occurring
disorders benefited slightly less than others.
Godley and colleagues (2002, 2004, 2007) devel-
oped a protocol called assertive continuing care (ACC)
and showed that it improved participation and recov-
ery indicators. Researchers randomly assigned 183 ado-
lescents in residential treatment to either ACC or usual
continuing care (UCC). Adolescents in the ACC group
worked with a case manager who tried to meet with them
once before discharge. Subsequently, the case managers
provided in-home outpatient treatment and helped nego-
tiate additional treatment services, school support, pro-
bation, and other services to support recovery. All the
adolescents in both intervention groups were referred
to local outpatient treatment programs and self-help
groups, and were given continuing care plans. Over the
90 days following discharge, those who received ACC:
• Were more likely than those given UCC to access at
least some continuing care services (94 vs. 54 percent);
• Received more days of continuing care sessions (median
14.1 vs. 6.3);
• Were more likely to engage in 7 or more of 12 activi-
ties associated with sustaining abstinence (e.g., self-
help, urine testing, relapse prevention work; 64 vs. 35
percent); and
• Were more likely to remain abstinent 1 to 3 months
after discharge from residential treatment (43 vs. 24
percent), 
• Which was, in turn, predictive of abstinence 4 to 9
months after discharge (69 vs. 19 percent). 
The research team is currently exploring whether
contingency contracting can further improve contin-
uing care participation and related outcomes and whether
ACC can improve outcomes following outpatient treat-
ment.
On a broader scale, various groups have suggested
using performance measurement to improve continu-
ity of care (e.g., Garnick et al., 2002; McCorry et al.,
2000; McLellan et al., 2005; www.ncqa.org; www.
washingtoncircle.org). One of the largest such initia-
tives, the Network for the Improvement of Addiction
Treatment (NIATx), is a partnership among the Center
for Substance Abuse Treatment, the Robert Wood Johnson
Foundation, and a number of independent addiction
treatment organizations (Capoccia et al., 2007; McCarty
et al., 2007; Wisdom et al., 2006). The NIATx mission
is to improve the efficiency with which the treatment
field uses its capacity and to encourage ongoing improve-
ments in treatment access and retention. NIATx assumes
that addiction is a chronic and progressive condition
and that interruptions and delays in the continuity of
care can seriously exacerbate consequences. Using a
process-improvement model, the first 13 NIATx pro-
grams were able to reduce the time from an individual’s
first contact to treatment entry by 37 percent, and from
the first assessment to first treatment episode by 33 per-
cent. They also improved the rate of returning for the
second treatment session by 18 percent and the likeli-
hood of staying four or more sessions by 11 percent
(McCarty et al., 2007).
Monitoring and Early Reintervention
Ongoing monitoring and early reintervention have
improved long-term outcomes for a range of chronic
conditions, including asthma, cancer, diabetes, depres-
sion, and severe mental illness (Dunbar-Jacob et al.,
1995; Engel, 1977, 1980; Huber, 2005; Institute of
Medicine, 2001; McLellan et al., 2005; Nicassio and
Smith, 1995; Roter et al., 1998; Weisner et al., 2004).
Applying this approach to SUDs, Scott and Dennis
(2003) developed and tested the recovery management
checkup (RMC). With RMC, treatment staff mem-
bers do not rely on patients to recognize that they need
help but instead conduct quarterly checkups to assess
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patient status. Staff members use motivational inter-
viewing techniques to assist those who have relapsed
to resolve their ambivalence about their substance use
and commit to treatment or other appropriate care.
Staff members also deploy assertive treatment linkage,
engagement, and retention protocols to secure patient
access to treatment and increase the amount of ther-
apy received.
The initial clinical trial of RMC randomly assigned
448 adults, when they first presented for treatment, to
post-treatment followup with the checkup intervention
or only quarterly monitoring (Figure 3; Dennis, Scott,
and Funk, 2003; Scott, Dennis, and Foss, 2005). At the
end of 2 years of followup, the results showed that patients
in the RMC group:
• Returned to treatment in greater numbers (60 vs. 
51 percent)
• Returned to treatment sooner (median 376 vs. 600
days) 
• Attended treatment on more days (average 63 
vs. 40)
• Were less likely to be in need of treatment after 2 years
(34 vs. 44 percent).
A second clinical trial, with 446 patients, used a mod-
ified RMC protocol and produced parallel findings.
These two trials indicate that ongoing monitoring and
early reintervention can promote positive patient behav-
iors in long-term substance use.
Other Recovery Support Initiatives
Individuals with an SUD, like those with other chronic
conditions, require a variety of support services to
help manage their condition during and between episodes
of formal treatment. Research demonstrates that active
participation in self-help groups during and after treat-
ment promotes lengthier periods of recovery (Brown,
1993; Hsieh, Hoffman, and Hollister, 1998; Humphreys
and Moos, 2001; Kyrouz, Humphreys, and Loomis,
2002; McKay et al., 2002; Ritsher et al., 2002; Scott,
Dennis, and Foss, 2005). Preliminary evidence also sug-
gests that self-help participation is associated with bet-
ter outcomes when patients join groups that focus on
their particular issues, such as dual diagnoses (Laudet et
al., 2000) or adolescent issues (Finch, 2005; Kelly and
Myers, 1997; Kelly, Myers, and Brown 2002; White and
Finch, 2006). Other recently tested recovery support
approaches include telephone-based self-monitoring
(Simpson et al., 2005) and Internet-based groups (Klaw,
Huebsch, and Humphreys, 2000; Kypri et al., 2005;
Toll et al., 2003). A meta-analysis of 24 studies involv-
ing 3,739 participants with chronic health conditions
(other than SUDs) suggests that Internet-based inter-
ventions that allow interactions between patients and
staff have a significantly higher impact than sites pro-
viding information only (Murray et al., 2004). 
Connecticut and other states have begun to add
recovery-based performance measures, values, and con-
tinuity of care between professional and “peer-based
recovery supports” to their recovery initiatives (www.dmhas.
state.ct.us/recovery.htm). Similarly, in 2003, the Arizona
Department of Health Services embarked on a unique
initiative designed to develop a “peer workforce” for per-
sons with SUDs (azdhs.gov/bhs/bhsglance.pdf). Public
health systems that provide addiction, mental health,
child welfare, and other services in Connecticut, Arizona,
and other jurisdictions target key subgroups of people
with SUDs to interrupt the cycle of relapse, treatment
reentry, and recovery. For example, parents with SUDs
can access standardized screening, colocated services,
intensive case managers, or recovery coaches to facili-
tate long-term treatment engagement (e.g., Loveland
and Boyle, 2005; Ryan, Louderman, and Testa, 2003). 
IMPLICATIONS FOR PRACTICE
Whether a program implements one of the approaches
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In the 24 months following discharge from an index episode of care, the rate of
readmission was higher (64% versus 51%) and the median time to readmission
was shorter (376 vs. 600 days) among patients who the received recovery manage-
ment checkup intervention, compared to controls. [Adapted from Dennis, Scott,
and Funk, 2003; with permission from Elsevier.]
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we have described or others yet to be developed, the lit-
erature suggests that programs should take their resources
and capacities into account when choosing which empir-
ically proven efficacious programs to implement to
improve care. Lipsey and colleagues (2001), in a meta-
analysis, demonstrated that the thoroughness of imple-
mentation can markedly affect the efficacy of evidence-
based interventions. The researchers recommended that
programs implement the most efficacious program they
can implement well, because a highly efficacious pro-
gram will not yield any better results for patients if it is
implemented poorly. Such findings have led the National
Institutes of Health to emphasize the need to improve
the state of “implementation science” (e.g., grants.
nih.gov/grants/guide/pa-files/PAR-06-039.html). Based
on a recent review of the implementation science liter-
ature, Fixsen and colleagues (2005) suggested that efforts
to implement new approaches should generally include
implementation strategies at multiple levels, including
but not limited to Federal, state, and local stakeholders,
and staff across all levels of the provider organizations.
Shifting from an acute care to a chronic care model
of recovery has implications for addiction programs,
as well as for external stakeholders in those programs,
and proper implementation of a chronic care model is
crucial to its efficacy.
Organizational Support for a Chronic Care
Approach
The philosophical, financial, clinical, and practical impli-
cations of moving to a chronic care approach will touch
everyone in an addiction treatment organization—its
board of directors, management, clinical supervisors and
line staff, administrative supports, and clients. Consider
what is required, for example, to respond appropriately
when a person returns for his or her fourth episode of
care: intake and admission procedures must be stream-
lined to facilitate rapid interruption of crises or relapses;
patient and staff assumptions that multiple treatments
represent failure must give way to attitudes more aligned
with the standards we apply to treating other chronic
conditions that need long-term management; and the
funding structure will need to provide the necessary
financial support. 
In addition, as we learn more about the factors
that influence patients’ progress in different phases of
recovery, we will likely need greater resources and infra-
structure to organize this information so that it can sup-
port real-time clinical decision making. It may be nec-
essary to modify assessment and other record systems to
transfer information readily when patients move between
levels of care and to make them accessible to multiple
staff on the treatment team. Addressing such issues is
likely to be critical for improving the management of
SUDs.
Even when staff members favor the change to a chronic
care model, they may not have adequate training, edu-
cation, experience, or resources to address the needs of
a particular client comprehensively—ranging, for exam-
ple, from making psychiatric referrals to helping with
housing. Miller and colleagues (2006) suggest that pro-
grams need to equip staff with three types of infrastructure
before change can happen efficiently:
• Preparatory knowledge, which may be inculcated 
through reading, verbal instruction, or observing com-
petent practice by others;
• Practice with feedback—of note, early practice dur-
ing or right after training without feedback can rein-
force bad habits and do as much harm as good; and
• Ongoing coaching or supervision, which is essential,
because practice will inevitably bring up a wide range
of situations and complex scenarios not covered in the
basic materials or training.
Even experienced clinicians benefit from opportu-
nities to brainstorm with staff colleagues on ways to han-
dle a new situation or adapt a protocol when neces-
sary. When Miller and colleagues (2004) randomized
140 counselors to a wait list condition or four training
conditions (workshop, workshop + practice feedback,
workshop + coaching, workshop + feedback + coach-
ing), all training conditions improved knowledge and
proficiency, but actual practice changed only when both
feedback and coaching were provided. Although this
particular study focused on a specific intervention, these
three components will likely be important factors when
implementing many key changes necessary to move
toward a chronic-care model.
Federal, State, and Local Stakeholders
Public payers, government regulators, and accrediting
bodies set requirements and impose limits on what pub-
licly funded treatment providers can accomplish in terms
of adopting a chronic-care approach to treating SUDs.
More than three-quarters of the people accessing addic-
tion treatment receive some kind of public assistance
(Substance Abuse and Mental Health Services Admin-
istration, 2006); this makes public fund providers the
primary purchasers of services and gives them a unique
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clients with SUDs and their families by stating that the
majority of people do succeed and the likelihood of reach-
ing recovery status is related to continuing care and ongo-
ing recovery support. When relapse occurs, staff should
explain the chronic nature of the condition, proactively
refer those in relapse to continuing care and other serv-
ices, and work with patients to ensure that they follow
through with recommendations for continuing care, for
self-help group meetings, for ongoing urine monitor-
ing, and for services to address other problems.
CONCLUSION
Historically, addiction treatment has been conceptual-
ized as an episodic relationship in which a person
seeks treatment, receives an assessment, and then is treated
and presumed cured—all in a relatively short time period.
Although the field faces numerous challenges in its
attempts to manage chronic SUDs more effectively, this
review demonstrates that we are making progress. Indeed,
it has been argued that addiction treatments appear to
be as effective as interventions available for other chronic
conditions such as diabetes and hypertension (McLellan
et al., 2000). The growing body of empirical evidence
demonstrating the chronicity of SUDs, coupled with
increasing awareness among various stakeholders about
the need for change, represents genuine progress. Formal
and informal efforts to address the problems continue
to expand; it is hoped that this enhanced awareness will
lead to increased dialogue and action among the numer-
ous stakeholders to improve the treatment and long-
term management of chronic SUDs.
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ability to reshape existing structures and policies. As one
example of the constructive use of this power, McLellan
(2006) recently reported preliminary data from Delaware
demonstrating that offering treatment providers 
performance-based incentives can improve the system
of care. The data showed that retention rates from 2002
to 2004 increased 30 days (48 to 69 percent) and 60
days (25 to 42 percent) after admission. The State of
Massachusetts implements a continuum of care based
on the chronic disease model for its prevention and treat-
ment systems (www.mass.gov/dph/bsas/sa_strategic_plan.
ppt). In an attempt to more effectively address the chronic
aspects of addiction, Connecticut is reviewing and mod-
ifying its regulations, services, and training to focus more
on recovery values, recovery-based performance meas-
ures, and continuity of care between professional and
“peer-based recovery” supports (www.dmhas.state.
ct.us/recovery.htm). Although these and other efforts
across the United States are encouraging first steps in
the change process, adopting a chronic-care approach
will require buy-in and active participation from all con-
cerned with reducing the health and social consequences
of drug abuse and addiction.
NEXT STEPS
Recent studies suggest some initial approaches to chronic
care management. However, the field would benefit from
research that investigates (1) the costs of ongoing mon-
itoring and early reintervention; (2) the chronic care
model in different populations (e.g., pregnant and post-
partum women, offenders leaving prison, and adoles-
cents); (3) the point at which an individual’s recovery
history and status warrant transition from quarterly to
biannual checkups; (4) the usefulness of more frequent
or even continuous monitoring in improving outcomes;
(5) the impact of less formal types of care (e.g., recovery
coaches or faith-based interventions); (6) modes of serv-
ice delivery such as telephone and e-mail; and (7) the
indirect effects of recovery management on other out-
comes such as HIV infection, illegal activity, emotional
problems, vocational activity, and quality of life.
This information can help individuals and their fam-
ilies, and treatment staff recognize that addiction is a
chronic but treatable condition, that most people with
SUDs need help from several sources, that recovery often
takes multiple episodes of treatment, and that relapse is
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